Valuation : DIAGNOS Inc.

Market Cap 5.96Cr 4.29Cr 3.7Cr 3.48Cr 3.17Cr 406.94Cr 5.99Cr 41Cr 16Cr 207Cr 16Cr 16Cr 686.39Cr P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 5.91Cr 4.25Cr 3.67Cr 3.45Cr 3.14Cr 403.36Cr 5.94Cr 41Cr 16Cr 205.18Cr 16Cr 16Cr 680.34Cr EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
95.32%
Yield 2025 *
-
Yield 2026 -
1 day-1.00%
1 week+20.73%
Current month-1.00%
1 month+80.00%
3 months+115.22%
6 months+65.00%
Current year+32.00%
1 week 0.46
Extreme 0.455
0.52
1 month 0.28
Extreme 0.28
0.52
Current year 0.18
Extreme 0.175
0.52
1 year 0.18
Extreme 0.175
0.52
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Option

Director

-1,00,000 0.0830%
21/08/26 Option

Director

1,00,000 0.0830%
19/08/26 Option

Director

-1,66,666 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%+20.73%+83.33%-4.81% 4.29Cr
-1.06%-1.19%-4.97%+56.41% 22TCr
-0.88%+0.62%-27.65%-42.61% 12TCr
-3.51%+0.88%+34.00%+103.59% 11TCr
-1.11%+3.22%-24.70%-31.46% 9.03TCr
-1.50%+0.53%-23.20%+2.06% 6.22TCr
-1.35%+1.86%-23.88%-22.14% 4.93TCr
-3.78%+2.21%+6.93%+105.19% 4.28TCr
-5.05%+1.76%+8.02%+202.74% 4.15TCr
-1.41%+2.59%-9.12%+8.08% 3.85TCr
Average -2.06%+4.20%+1.88%+37.71% 7.69TCr
Weighted average by Cap. -1.83%+1.24%-6.59%+36.81%

Financials

2025 2026
Net sales 1L 74.67T 64.41T 60.59T 55.2T 70.87L 1L 7L 3L 36.05L 3L 3L 1.2Cr 65.48T 47.1T 40.63T 38.22T 34.82T 44.7L 65.83T 5L 2L 22.74L 2L 2L 75.4L
Net income -42.86L -30.84L -26.6L -25.02L -22.79L -29Cr -43.1L -2.96Cr -1.15Cr -15Cr -1.16Cr -1.13Cr -49Cr -45.55L -32.77L -28.27L -26.59L -24.22L -31Cr -45.8L -3.14Cr -1.22Cr -16Cr -1.23Cr -1.2Cr -52Cr
Net Debt -2L -1L -1L -95.56T -87.05T -1.12Cr -2L -11.3L -4L -56.85L -4L -4L -1.89Cr -5L -4L -3L -3L -3L -3.59Cr -5L -36.24L -14.1L -1.82Cr -14.18L -13.88L -6.05Cr
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
01/26/01 CA$0.4950 -1.00% 4,93,334
31/26/31 CA$0.5000 0.00% 1,43,124
28/26/28 CA$0.5000 +2.04% 3,47,450
27/26/27 CA$0.4900 +5.38% 4,04,132
26/26/26 CA$0.4650 +13.41% 7,55,679

Annual profits - Rate of surprise